BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 6609929)

  • 21. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
    Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
    No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of kinetic rate constants in [18F]fluorodeoxyglucose model using a least square fitting package SALS (statistical analysis with least squares).
    Uehara S; Kuwabara Y; Ichiya Y; Otsuka M; Ayabe Y; Miyake Y; Masuda K; Yoshimura A
    Radioisotopes; 1987 Dec; 36(12):653-6. PubMed ID: 3502293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.
    Roelcke U; Kappos L; Lechner-Scott J; Brunnschweiler H; Huber S; Ammann W; Plohmann A; Dellas S; Maguire RP; Missimer J; Radü EW; Steck A; Leenders KL
    Neurology; 1997 Jun; 48(6):1566-71. PubMed ID: 9191767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
    Herholz K; Rudolf J; Heiss WD
    J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
    Kuwabara H; Gjedde A
    J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of biological and technical factors on the variability of global and regional brain metabolism of 2-[18F]fluoro-2-deoxy-D-glucose.
    Camargo EE; Szabo Z; Links JM; Sostre S; Dannals RF; Wagner HN
    J Cereb Blood Flow Metab; 1992 Mar; 12(2):281-90. PubMed ID: 1548300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional cerebral glucose utilization in chronic organic mental disorders associated with alcoholism.
    Martin PR; Rio D; Adinoff B; Johnson JL; Bisserbe JC; Rawlings RR; Rohrbaugh JW; Stapleton JM; Eckardt MJ
    J Neuropsychiatry Clin Neurosci; 1992; 4(2):159-67. PubMed ID: 1627977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
    Brooks DJ; Beaney RP; Lammertsma AA; Herold S; Turton DR; Luthra SK; Frackowiak RS; Thomas DG; Marshall J; Jones T
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data.
    Dhawan V; Moeller JR; Strother SC; Evans AC; Rottenberg DA
    J Nucl Med; 1989 Sep; 30(9):1483-8. PubMed ID: 2788721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P; Dive D; Salmon E; von Frenckel R; Franck G
    Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of local cerebral glucose utilization by positron emission tomography of [18F]2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures.
    Wienhard K; Pawlik G; Herholz K; Wagner R; Heiss WD
    J Cereb Blood Flow Metab; 1985 Mar; 5(1):115-25. PubMed ID: 3871780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study.
    Kinnala A; Suhonen-Polvi H; Aärimaa T; Kero P; Korvenranta H; Ruotsalainen U; Bergman J; Haaparanta M; Solin O; Nuutila P; Wegelius U
    Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F153-7. PubMed ID: 8777676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography study of human brain functional development.
    Chugani HT; Phelps ME; Mazziotta JC
    Ann Neurol; 1987 Oct; 22(4):487-97. PubMed ID: 3501693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional cerebral glucose transport and utilization in Alzheimer's disease.
    Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
    Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil.
    Price JC; Mayberg HS; Dannals RF; Wilson AA; Ravert HT; Sadzot B; Rattner Z; Kimball A; Feldman MA; Frost JJ
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):656-67. PubMed ID: 8391018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional differences in cerebral blood flow and glucose utilization in diabetic man: the effect of insulin.
    Cranston I; Marsden P; Matyka K; Evans M; Lomas J; Sonksen P; Maisey M; Amiel SA
    J Cereb Blood Flow Metab; 1998 Feb; 18(2):130-40. PubMed ID: 9469154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.
    Vollenweider FX; Leenders KL; Scharfetter C; Maguire P; Stadelmann O; Angst J
    Neuropsychopharmacology; 1997 May; 16(5):357-72. PubMed ID: 9109107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography.
    Wu JC; Gillin JC; Buchsbaum MS; Hershey T; Hazlett E; Sicotte N; Bunney WE
    Sleep; 1991 Apr; 14(2):155-62. PubMed ID: 1866529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid feasibility studies of tracers for positron emission tomography: high-resolution PET in small animals with kinetic analysis.
    Ingvar M; Eriksson L; Rogers GA; Stone-Elander S; Widén L
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):926-31. PubMed ID: 1939386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.